{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:39:58Z","timestamp":1784133598111,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.kint.2025.02.010","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T04:07:54Z","timestamp":1740456474000},"page":"916-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Guanidinylation compromises the anti-inflammatory and anti-oxidative properties of\u00a0apolipoprotein A-I in chronic kidney disease progression"],"prefix":"10.1016","volume":"107","author":[{"given":"Andrea","family":"Bonnin-Marquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne L.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kahles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Lellig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Fliser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7472-4907","authenticated-orcid":false,"given":"Eleni","family":"Stamellou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-6393","authenticated-orcid":false,"given":"Thimoteus","family":"Speer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahir","family":"Kalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dickson Wai","family":"Leong Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel P.C.","family":"van der Vorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.02.010_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.02.010_bib2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.02.010_bib3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.02.010_bib4","article-title":"Overview of oxLDL and its impact on cardiovascular health: focus on atherosclerosis","volume":"11","author":"Poznyak","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.kint.2025.02.010_bib5","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2025.02.010_bib6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2013050482","article-title":"HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction","volume":"25","author":"Zewinger","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/biomedicines8120549","article-title":"High-density lipoprotein modifications: a pathological consequence or cause of disease progression?","volume":"8","author":"Marquez","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.kint.2025.02.010_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.kint.2025.02.010_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneph.2015.180","article-title":"HDL abnormalities in nephrotic syndrome and chronic kidney disease","volume":"12","author":"Vaziri","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib10","doi-asserted-by":"crossref","first-page":"F511","DOI":"10.1152\/ajprenal.00508.2015","article-title":"Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function","volume":"310","author":"Sun","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2025.02.010_bib11","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1089\/ars.2010.3640","article-title":"Protein carbamylation renders high-density lipoprotein dysfunctional","volume":"14","author":"Holzer","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.kint.2025.02.010_bib12","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.2019111205","article-title":"CKD increases carbonylation of HDL and is associated with impaired antiaggregant properties","volume":"31","author":"Florens","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/apha.12518","article-title":"Guanidinylations of albumin decreased binding capacity of hydrophobic metabolites","volume":"215","author":"Rueth","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.kint.2025.02.010_bib14","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2025.02.010_bib15","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1681\/ASN.2021040503","article-title":"Guanidinylated apolipoprotein C3 (ApoC3) associates with kidney and vascular injury","volume":"32","author":"Schunk","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib16","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0076-6879(67)11072-0","article-title":"[70] Guanidination of proteins","volume":"11","author":"Kimmel","year":"1967"},{"key":"10.1016\/j.kint.2025.02.010_bib17","doi-asserted-by":"crossref","first-page":"12291","DOI":"10.1073\/pnas.94.23.12291","article-title":"Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation","volume":"94","author":"Borhani","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2025.02.010_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2025.02.010_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11883-021-00906-7","article-title":"APOA1: a protein with multiple therapeutic functions","volume":"23","author":"Cochran","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.kint.2025.02.010_bib20","doi-asserted-by":"crossref","first-page":"C1538","DOI":"10.1152\/ajpcell.00467.2009","article-title":"Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages","volume":"298","author":"Smythies","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2025.02.010_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41581-024-00837-x","article-title":"Post-translational modifications in kidney diseases and associated cardiovascular risk","volume":"20","author":"Noels","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib22","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1681\/ASN.2016030336","article-title":"Clot structure: a potent mortality risk factor in patients on hemodialysis","volume":"28","author":"Schuett","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00125-006-0574-z","article-title":"The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase","volume":"50","author":"Nobecourt","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2025.02.010_bib24","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2025.02.010_bib25","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00125-007-0718-9","article-title":"Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties","volume":"50","author":"Hoang","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2025.02.010_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0021-9258(18)70634-0","article-title":"The reaction of O-methylisourea with bovine pancreatic ribonuclease","volume":"229","author":"Klee","year":"1957","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2025.02.010_bib27","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.02.010_bib28","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/j.1523-1755.2004.00631.x","article-title":"In\u00a0vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection","volume":"65","author":"Glorieux","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.02.010_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","article-title":"Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans","volume":"109","author":"Kielstein","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.02.010_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000320765","article-title":"Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in\u00a0vitro evaluation","volume":"30","author":"Schepers","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.kint.2025.02.010_bib31","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","volume":"38","author":"Zewinger","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2025.02.010_bib32","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1523-1755.2005.00238.x","article-title":"Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds","volume":"67","author":"Eloot","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.02.010_bib33","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1021\/acs.jproteome.8b00100","article-title":"A\u00a0targeted, differential top-down proteomic methodology for comparison of apoA-I proteoforms in individuals with high and low HDL efflux capacity","volume":"17","author":"Seckler","year":"2018","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.kint.2025.02.010_bib34","article-title":"Spectrum of apolipoprotein AI and apolipoprotein AII proteoforms and their associations with indices of cardiometabolic health: the CARDIA study","volume":"10","author":"Wilkins","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2025.02.010_bib35","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1021\/ac015613o","article-title":"Optimisation of guanidination procedures for MALDI mass mapping","volume":"74","author":"Beardsley","year":"2002","journal-title":"Anal Chem"},{"key":"10.1016\/j.kint.2025.02.010_bib36","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1681\/ASN.2014030309","article-title":"Dialysis modalities and HDL composition and function","volume":"26","author":"Holzer","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib37","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/toxins11110671","article-title":"Proteomic characterisation of high-density lipoprotein particles from non-diabetic hemodialysis patients","volume":"11","author":"Florens","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.kint.2025.02.010_bib39","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/01.ASN.0000117286.85443.7D","article-title":"Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study","volume":"15","author":"Okubo","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10157-013-0881-x","article-title":"In\u00a0vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease","volume":"18","author":"Ikewaki","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1744-9987.2012.01102.x","article-title":"High prevalence of anti-apolipoprotein\/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage","volume":"16","author":"Pruijm","year":"2012","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.kint.2025.02.010_bib42","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehu111","article-title":"Carbamylated low-density lipoprotein induces endothelial dysfunction","volume":"35","author":"Speer","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2025.02.010_bib43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5551\/jat.19448","article-title":"Oxidised high-density lipoprotein induces the proliferation and migration of vascular smooth muscle cells by promoting the production of ROS","volume":"21","author":"Wang","year":"2014","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.kint.2025.02.010_bib44","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1681\/ASN.2010040365","article-title":"Chronic uremia stimulates LDL carbamylation and atherosclerosis","volume":"21","author":"Apostolov","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib45","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1681\/ASN.2012030254","article-title":"Protein carbamylation predicts mortality in ESRD","volume":"24","author":"Koeth","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.02.010_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.109.201715","article-title":"Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I","volume":"30","author":"Nobecourt","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825001711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825001711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:26:07Z","timestamp":1777695967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825001711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0085253825001711"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.02.010","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guanidinylation compromises the anti-inflammatory and anti-oxidative properties of\u00a0apolipoprotein A-I in chronic kidney disease progression","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}